Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study.

IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Marco Meloni, Luigi Uccioli, Aikaterini Andreadi, Laura Giurato, Valeria Ruotolo, Maria Romano, Alessandro Minasi, Ermanno Bellizzi, Federico Rolando Bonanni, Martina Salvi, Alfonso Bellia, Davide Lauro
{"title":"Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study.","authors":"Marco Meloni, Luigi Uccioli, Aikaterini Andreadi, Laura Giurato, Valeria Ruotolo, Maria Romano, Alessandro Minasi, Ermanno Bellizzi, Federico Rolando Bonanni, Martina Salvi, Alfonso Bellia, Davide Lauro","doi":"10.1007/s00592-025-02577-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The study aimed to evaluate the rate and causes of major amputation in patients with diabetic foot syndrome.</p><p><strong>Methods: </strong>The current study is a retrospective observational study including consecutive patients referred to a tertiary-level diabetic foot service from January 2020 to November 2023 due to a new diabetic foot problem requiring hospital admission. All patients had been managed by a multi-disciplinary diabetic foot team (MDFT) through a pre-set limb salvage protocol including the management of peripheral arterial disease, infection, foot offloading, and comorbidities. At 1 year of follow-up, the following outcomes measures were evaluated: rate of major amputation, clinical characteristics of amputees, and causes of major amputation.</p><p><strong>Results: </strong>Overall, 1226 patients referring for a diabetic foot problem and requiring hospitalization were screened for the study. Among them, 30 (2.4%) patients experienced major amputation. Amputees had 69.9±10.7 years, the majority were male (73.3%) with a prevalence of type 2 diabetes (93.3%) and a long diabetes duration (25.2±9.8 years). They showed several comorbidities such as ischaemic heart disease (83.3%), heart failure (46.7%), end-stage-renal-disease (26.7%), and in addition high rate of peripheral arterial disease (PAD) (86.7%), infected wounds (98.3%), and osteomyelitis (90%). Major amputation was mainly related to untreatable limb ischemia (failure of revascularization procedure) in 56.7% of cases, calcaneus osteomyelitis and necrotizing fasciitis in 16.7% of cases, and tarsal osteomyelitis in 10% of cases.</p><p><strong>Conclusions: </strong>The rate of major amputation was very low in this population managed by a MDFT. PAD was the main cause of major amputation.</p>","PeriodicalId":6921,"journal":{"name":"Acta Diabetologica","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Diabetologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00592-025-02577-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The study aimed to evaluate the rate and causes of major amputation in patients with diabetic foot syndrome.

Methods: The current study is a retrospective observational study including consecutive patients referred to a tertiary-level diabetic foot service from January 2020 to November 2023 due to a new diabetic foot problem requiring hospital admission. All patients had been managed by a multi-disciplinary diabetic foot team (MDFT) through a pre-set limb salvage protocol including the management of peripheral arterial disease, infection, foot offloading, and comorbidities. At 1 year of follow-up, the following outcomes measures were evaluated: rate of major amputation, clinical characteristics of amputees, and causes of major amputation.

Results: Overall, 1226 patients referring for a diabetic foot problem and requiring hospitalization were screened for the study. Among them, 30 (2.4%) patients experienced major amputation. Amputees had 69.9±10.7 years, the majority were male (73.3%) with a prevalence of type 2 diabetes (93.3%) and a long diabetes duration (25.2±9.8 years). They showed several comorbidities such as ischaemic heart disease (83.3%), heart failure (46.7%), end-stage-renal-disease (26.7%), and in addition high rate of peripheral arterial disease (PAD) (86.7%), infected wounds (98.3%), and osteomyelitis (90%). Major amputation was mainly related to untreatable limb ischemia (failure of revascularization procedure) in 56.7% of cases, calcaneus osteomyelitis and necrotizing fasciitis in 16.7% of cases, and tarsal osteomyelitis in 10% of cases.

Conclusions: The rate of major amputation was very low in this population managed by a MDFT. PAD was the main cause of major amputation.

糖尿病足溃疡患者主要截肢的发生率和原因:来自回顾性研究的数据。
目的:探讨糖尿病足综合征患者主要截肢的发生率及原因。方法:本研究是一项回顾性观察性研究,纳入了从2020年1月至2023年11月因新的糖尿病足问题需要住院的三级糖尿病足服务的连续患者。所有患者均由多学科糖尿病足小组(MDFT)通过预先设定的肢体保留方案进行管理,包括外周动脉疾病、感染、足部卸载和合并症的管理。在1年的随访中,评估了以下指标:大截肢率、截肢者的临床特征和大截肢的原因。结果:总的来说,1226例糖尿病足问题和需要住院治疗的患者被筛选为研究。其中大截肢30例(2.4%)。截肢者平均年龄为69.9±10.7岁,男性居多(73.3%),2型糖尿病患病率(93.3%),糖尿病病程较长(25.2±9.8年)。他们表现出一些合并症,如缺血性心脏病(83.3%)、心力衰竭(46.7%)、终末期肾病(26.7%),此外外周动脉疾病(PAD)(86.7%)、伤口感染(98.3%)和骨髓炎(90%)的高发率。大截肢主要与无法治愈的肢体缺血(血运重建手术失败)有关(56.7%),跟骨髓炎和坏死性筋膜炎占16.7%,跗骨骨髓炎占10%。结论:在该人群中,经MDFT治疗的大截肢率非常低。外周动脉是导致大面积截肢的主要原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Diabetologica
Acta Diabetologica 医学-内分泌学与代谢
CiteScore
7.30
自引率
2.60%
发文量
180
审稿时长
2 months
期刊介绍: Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信